Correlation of ovarian adnexal reporting and data system classification with histopathological examination in diagnosis of adnexal masses
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250197Keywords:
Histopathology report, Ovarian adnexal reporting and data system, Preoperative diagnosis, Sensitivity and specificity, Staging laparotomyAbstract
Background: Adnexal masses are common and present significant clinical challenges related to diagnostic imaging, surgery and pathology. Ovarian adnexal reporting and data system (O-RADS) serves as both a lexicon and risk stratification tool, which is designed to accurately characterize adnexal lesions and facilitate optimal patient management. This study aimed to evaluate the diagnostic accuracy of O-RADS using histopathological examination as the gold standard.
Methods: This was a prospective observational study conducted in the department of Obstetrics and Gynaecology, Radio-diagnosis, Pathology in collaboration with the department of radio-diagnosis and pathology at Government Medical College and Hospital, Chandigarh from December 2022 to March 2024. A total of 35 women who were diagnosed with adnexal masses were included in the study.
Results: The age group of presentation of adnexal masses in our study was 14 to 62 years of age with a mean age of 31.69±11.25 years. O-RADS score 2 was 100% sensitive and 21.4% specific for detecting benign adnexal masses. ORADS score 3 was 100% sensitive and 24% specific for detecting benign masses. O-RADS score 4 was 25% sensitive and 89.47% specific for detecting malignant adnexal masses. Similarly, ORADS score 5 was 100% sensitive and 87.88% specific for detecting malignant masses using histopathology as the gold standard.
Conclusions: The ORADS classification system has a high sensitivity in differentiating between benign and malignant lesions when correlated with gold standard histopathology report.
Metrics
References
GLOBOCAN (2008). Estimated cancer Incidence, Mortality, Prevalence and Disability-adjusted life years (DALYs) Worldwide in 2008. October 28th, 2012. Available at: http://globocan.iarc.fr/. Accessed On 20 May 2024.
Forstner R, Thomassin-Naggara I, Cunha TM, Kinkel K, Masselli G, Kubik-Huch R, et al. ESUR recommendations for MR imaging of the sonographically indeterminate adnexal mass: an update. Eur Radiol. 2017;27:2248-57. DOI: https://doi.org/10.1007/s00330-016-4600-3
Geomini P, Kruitwagen R, Bremer GL, Cnossen J, Mol BW. The accuracy of risk scores in predicting ovarian malignancy: a systematic review. Obstet Gynecol. 2009;113:384-94. DOI: https://doi.org/10.1097/AOG.0b013e318195ad17
Kaijser J, Bourne T, Valentin L, Sayasneh A, Van Holsbeke C, Vergote I, et al. Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies. Ultrasound Obstet Gynecol. 2013;41:9-20. DOI: https://doi.org/10.1002/uog.12323
Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C, et al. Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic study. BMJ. 2014;349:g5920 DOI: https://doi.org/10.1136/bmj.g5920
Basha MA, Metwally MI, Gamil SA, Abdelaziz S, Ahmed SR, Ibrahim EM, et al. Comparison of O-RADS, GI-RADS, and IOTA simple rules regarding malignancy rate, validity, and reliability for diagnosis of adnexal masses. Eur Radiol. 2021;31:674-84. DOI: https://doi.org/10.1007/s00330-020-07143-7
Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, et al. O-RADS US risk stratification and management system: a consensus guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee. Radiology. 2020;294:168-85. DOI: https://doi.org/10.1148/radiol.2019191150
ACR Organisation. Ovarian-Adnexal Reporting and Data System (O-RADS): Ovarian Cancer Facts. 2020. Available at: https://www.acr.org/-/media/ACR/Files/RADS/O-RADS/Ovarian-Cancer-Facts-Final.pdf. Accessed on 20 May 2024.
American College of Radiology Committee on O-RADS™️ (Ovarian and Adnexal). O-RADS US v2022. January 1st, 2023. Accessed at: https://www.acr.org/-/media/ACR/Files/RADS/O-RADS/O-RADS-US-v2022-Sample-reports-FINAL.pdf. Accessed on 20 May 2024.
Strachowski LM, Jha P, Phillips CH, Blanchette Porter MM, Froyman W, Glanc P, et al. O-RADS US v2022: an update from the American College of Radiology’s Ovarian-Adnexal Reporting and Data System US Committee. Radiology. 2023;308:230685-708. DOI: https://doi.org/10.1148/radiol.230685
Sneha C, Hiremath R, Bathrenathh B. Risk stratification and validation of ultrasound ovarian and adnexal reporting data system: Correlation with clinical follow-up and histopathology. Int J Radiol Diagn Imag. 2023;6:125-33. DOI: https://doi.org/10.33545/26644436.2023.v6.i1b.316
Jha P, Gupta A, Baran TM, Maturen KE, Patel-Lippmann K, Zafar HM, et al. Diagnostic performance of the ovarian-adnexal reporting and data system (O-RADS) ultrasound risk score in women in the United States. J Am Med Assoc Netw Open. 2022;5:2216370-80. DOI: https://doi.org/10.1001/jamanetworkopen.2022.16370
Ahmed AS, AbdAlrahman HA, Esmaiyl AA, Basha MA. Study of validity of O-RADS ultrasonography in risk stratification and management of adnexal masses. Egypt J Hosp Med. 2023;90:1570-8. DOI: https://doi.org/10.21608/ejhm.2023.282508
Tantawy HF, Ebrahim SA, Kamal MR, Hassan RM. The diagnostic performance of ultrasound in the diagnosis of indeterminate adnexal masses based on the O-RADS US scoring system. Egypt J Radiol Nucl Med. 2024;55:11-9. DOI: https://doi.org/10.1186/s43055-024-01184-4
Solis Cano DG, Cervantes Flores HA, De Los Santos Farrera O, Guzman Martinez NB, Soria Céspedes D. Sensitivity and specificity of ultrasonography using ovarian-adnexal reporting and data system classification versus pathology findings for ovarian cancer. Cureus. 2021;13(9): e17646. DOI: https://doi.org/10.7759/cureus.17646
Downloads
Published
How to Cite
Issue
Section
